• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Randomized, double-blinded, placebo controlled study to assess the effect of topical 1% nicotinamide on actinic keratoses.

作者信息

Moloney F, Vestergaard M, Radojkovic B, Damian D

出版信息

Br J Dermatol. 2010 May;162(5):1138-9. doi: 10.1111/j.1365-2133.2010.09659.x. Epub 2010 Mar 1.

DOI:10.1111/j.1365-2133.2010.09659.x
PMID:20199551
Abstract
摘要

相似文献

1
Randomized, double-blinded, placebo controlled study to assess the effect of topical 1% nicotinamide on actinic keratoses.一项随机、双盲、安慰剂对照研究，旨在评估外用1%烟酰胺对光化性角化病的疗效。
Br J Dermatol. 2010 May;162(5):1138-9. doi: 10.1111/j.1365-2133.2010.09659.x. Epub 2010 Mar 1.
2
Oral nicotinamide reduces actinic keratoses in phase II double-blinded randomized controlled trials.在II期双盲随机对照试验中，口服烟酰胺可减少光化性角化病。
J Invest Dermatol. 2012 May;132(5):1497-500. doi: 10.1038/jid.2011.459. Epub 2012 Feb 2.
3
Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis.0.025%和0.05%鬼臼毒素丁酯凝胶治疗光化性角化病的随机、双盲、双模拟、赋形剂对照研究
J Am Acad Dermatol. 2009 Jun;60(6):934-43. doi: 10.1016/j.jaad.2009.01.008.
4
A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention.一项烟酰胺用于皮肤癌化学预防的 3 期随机试验。
N Engl J Med. 2015 Oct 22;373(17):1618-26. doi: 10.1056/NEJMoa1506197.
5
Can topical calcipotriol be a treatment alternative in actinic keratoses? A preliminary report.外用卡泊三醇能否作为光化性角化病的一种治疗选择？一份初步报告。
J Drugs Dermatol. 2009 May;8(5):451-4.
6
PEP005 (ingenol mebutate) gel, a novel agent for the treatment of actinic keratosis: results of a randomized, double-blind, vehicle-controlled, multicentre, phase IIa study.PEP005（鬼臼毒素）凝胶，一种治疗光化性角化病的新型药物：一项随机、双盲、赋形剂对照、多中心IIa期研究的结果。
Australas J Dermatol. 2009 Feb;50(1):16-22. doi: 10.1111/j.1440-0960.2008.00497.x.
7
Nicotinamide and the skin.烟酰胺与皮肤。
Australas J Dermatol. 2014 Aug;55(3):169-75. doi: 10.1111/ajd.12163. Epub 2014 Mar 17.
8
Effect of a 1-week treatment with 0.5% topical fluorouracil on occurrence of actinic keratosis after cryosurgery: a randomized, vehicle-controlled clinical trial.0.5%外用氟尿嘧啶1周治疗对冷冻治疗后光化性角化病发生的影响：一项随机、赋形剂对照临床试验。
Arch Dermatol. 2004 Jul;140(7):813-6. doi: 10.1001/archderm.140.7.813.
9
Optimization of photodynamic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: results of two randomized controlled phase III studies.新型自粘式5-氨基乙酰丙酸贴片光动力疗法的优化：两项随机对照III期研究结果
Br J Dermatol. 2009 May;160(5):1066-74. doi: 10.1111/j.1365-2133.2009.09040.x. Epub 2009 Feb 16.
10
Randomized, double-blind, placebo-controlled prospective study of the efficacy of topical anaesthesia with a eutetic mixture of lignocaine 2.5% and prilocaine 2.5% for topical 5-aminolaevulinic acid-photodynamic therapy for extensive scalp actinic keratoses.利多卡因2.5%与丙胺卡因2.5% eutetic混合物用于广泛头皮光化性角化病的5-氨基酮戊酸光动力疗法局部麻醉疗效的随机、双盲、安慰剂对照前瞻性研究。
Br J Dermatol. 2006 Jan;154(1):146-9. doi: 10.1111/j.1365-2133.2005.06991.x.

引用本文的文献

1
From actinic keratosis to cutaneous squamous cell carcinoma: the key pathogenesis and treatments.从光化性角化病到皮肤鳞状细胞癌：关键发病机制与治疗方法
Front Immunol. 2025 Jan 24;16:1518633. doi: 10.3389/fimmu.2025.1518633. eCollection 2025.
2
Epidemiology and Risk Factors of Actinic Keratosis. What is New for The Management for Sun-Damaged Skin.光化性角化病的流行病学与危险因素。日光损伤皮肤管理的新进展。
Dermatol Pract Concept. 2024 Sep 1;14(3 S1):e2024146S. doi: 10.5826/dpc.1403S1a146S.
3
Niacinamide: a review on dermal delivery strategies and clinical evidence.
烟酰胺：皮肤递药策略及临床证据的综述。
Drug Deliv Transl Res. 2024 Dec;14(12):3512-3548. doi: 10.1007/s13346-024-01593-y. Epub 2024 May 9.
4
Topical Immunotherapy for Actinic Keratosis and Field Cancerization.光化性角化病和场癌化的局部免疫疗法。
Cancers (Basel). 2024 Mar 12;16(6):1133. doi: 10.3390/cancers16061133.
5
The Role of Nicotinamide as Chemo-Preventive Agent in NMSCs: A Systematic Review and Meta-Analysis.烟酰胺作为 NMSCs 化学预防剂的作用：系统评价和荟萃分析。
Nutrients. 2023 Dec 27;16(1):100. doi: 10.3390/nu16010100.
6
The role of sirtuins in dermal fibroblast function.沉默调节蛋白在皮肤成纤维细胞功能中的作用。
Front Med (Lausanne). 2023 Mar 13;10:1021908. doi: 10.3389/fmed.2023.1021908. eCollection 2023.
7
Pharmacological Agents Used in the Prevention and Treatment of Actinic Keratosis: A Review.用于光化性角化病预防和治疗的药物制剂：综述。
Int J Mol Sci. 2023 Mar 5;24(5):4989. doi: 10.3390/ijms24054989.
8
Effect of Nicotinamide in Skin Cancer and Actinic Keratoses Chemoprophylaxis, and Adverse Effects Related to Nicotinamide: A Systematic Review and Meta-Analysis.烟酰胺在皮肤癌和光化性角化病化学预防中的作用以及与烟酰胺相关的不良反应：一项系统评价和荟萃分析
J Cutan Med Surg. 2022 May-Jun;26(3):297-308. doi: 10.1177/12034754221078201. Epub 2022 Feb 8.
9
Sunscreen lotions in the dermatological prescription: review of concepts and controversies.皮肤科处方中的防晒霜：概念和争议综述。
An Bras Dermatol. 2022 Mar-Apr;97(2):204-222. doi: 10.1016/j.abd.2021.05.012. Epub 2022 Jan 14.
10
s-HBEGF/SIRT1 circuit-dictated crosstalk between vascular endothelial cells and keratinocytes mediates sorafenib-induced hand-foot skin reaction that can be reversed by nicotinamide.s-HBEGF/SIRT1 通路调控的血管内皮细胞与角质形成细胞间相互作用介导索拉非尼致手足皮肤不良反应，烟酰胺可逆转该不良反应。
Cell Res. 2020 Sep;30(9):779-793. doi: 10.1038/s41422-020-0309-6. Epub 2020 Apr 15.